Advertisement

Mixed Palette for Kansai Nerolac: Q4 Profit Dips 7%, Yet Revenue and Dividend Keep Investors in the Picture


Updated: May 06, 2025 23:25

Image Source: Stockgro

Stay Ahead – Explore Now! Piramal Pharma Solutions and IntoCell Forge Strategic Partnership to Accelerate ADC Development

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement